One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
- :
Price : 100$- Special Price : 50$
Correlations of the Complement Proteins MASP-2 and MASP-3 With Clinical Severity and Short-Term Outcomes in Primary Membranous Nephropathy Patients
doi : 10.1111/nep.70041
Evolving Gender Dynamics in India's Nephrology Workforce: A Decadal Analysis (2013–2023)
doi : 10.1111/nep.70047
Podocyte Infolding Glomerulopathy: Case Series From a Tertiary Hospital in India
doi : 10.1111/nep.70045
Executive Summary of the Asian Pacific Society of Nephrology Clinical Practice Guideline on Diabetic Kidney Disease—2025 Update
doi : 10.1111/nep.70031
The Significance of Menopausal Hormone Therapy on Cognitive Function in Women With CKD
doi : 10.1111/nep.70053
Diagnostic Potential of Dp-ucMGP as a Biomarker for Early Detection of Diabetic Kidney Disease in Patients With Type 2 Diabetes Mellitus: A Cross-Sectional Study
doi : 10.1111/nep.70050
Diagnostic Value and Mechanism of Action of Serum miR-1281 Involved in T2DM and Complications of DKD
doi : 10.1111/nep.70052
New Onset of Primary Membranous Nephropathy After COVID-19 mRNA Vaccination in Affected Sjögren's Syndrome
doi : 10.1111/nep.70048
Projection of the Prevalence and Economic Burden of Chronic Kidney Disease in Taiwan From 2022 to 2027 (Inside CKD): A Microsimulation Study
doi : 10.1111/nep.70055
Recognizing a Rare Presentation: Hypokalemic Periodic Paralysis Secondary to Amphetamine Use
doi : 10.1111/nep.70056
Non-Inferiority of Subcutaneous Efepoetin Alfa Compared to Methoxy Polyethylene Glycol-Epoetin Beta in Stage 3 or 4 CKD Patients: Insights From a Phase 3 Trial
doi : 10.1111/nep.70046
A Case of IgA Nephropathy With Membranoproliferative Glomerulonephritis-Like Features
doi : 10.1111/nep.70057
A Mendelian Randomization Study on the Association Between Sex Hormone-Binding Globulin and Membranous Nephropathy Risk
doi : 10.1111/nep.70049
